{"id":13584,"date":"2021-04-22T09:28:54","date_gmt":"2021-04-22T14:28:54","guid":{"rendered":"https:\/\/cornflowerblue-rail-980953.hostingersite.com\/?p=13584"},"modified":"2021-04-22T09:29:43","modified_gmt":"2021-04-22T14:29:43","slug":"whats-new-in-breast-imaging-spanish-april-2021","status":"publish","type":"post","link":"https:\/\/staging-hub.acoredu.com\/es\/whats-new-in-breast-imaging-spanish-april-2021\/","title":{"rendered":"What’s new in Breast Imaging (Spanish) – April 2021"},"content":{"rendered":"

Traducido por – <\/span><\/b>Luis Alberto <\/span>Albarado<\/span>\u00a0<\/span>\u00a0<\/span><\/p>\n

Rv<\/span><\/b> Daniela Segura – Radi\u00f3loga ACORE <\/span>Team<\/span> Leader Colombia<\/span>\u00a0<\/span><\/p>\n

\u00a0<\/span><\/p>\n

Vigilancia por im\u00e1genes de sobrevivientes de c\u00e1ncer de mama con mamograf\u00eda digital versus <\/b>tomos\u00edntesis<\/b> digital de mama<\/b>\u00a0<\/span><\/h5>\n

Bahl<\/span>, M., <\/span>Mercaldo<\/span>, S., <\/span>Mccarthy<\/span>, A. M., & <\/span>Lehman<\/span>, C. D. (2021). <\/span>\u00a0<\/span><\/p>\n

Imaging Surveillance of Breast Cancer Survivors with Digital Mammography versus Digital Breast Tomosynthesis. <\/span>\u00a0<\/span><\/p>\n

Radiology,<\/span><\/i> 298<\/span><\/i>(2), 308-316. doi:10.1148\/radiol.2020201854<\/span>\u00a0<\/span><\/p>\n

https:\/\/pubs.rsna.org\/doi\/full\/10.1148\/radiol.2020201854<\/span><\/a>\u00a0<\/span><\/p>\n

En este estudio, los autores trataron de comparar el rendimiento de la mamograf\u00eda digital bidimensional (M<\/span>D<\/span>) con la <\/span>tomos\u00edntesis<\/span> digital de mama (T<\/span>D<\/span>) para la vigilancia por im\u00e1genes de sobrevivientes de c\u00e1ncer de mama. Los ex\u00e1menes <\/span>MD<\/span> y <\/span>TD<\/span> de 8.170 mujeres obtenidos entre 2008 y 2017 fueron revisados retrospectivamente por radi\u00f3logos de mamas con la asistencia de detecci\u00f3n asistida por computadora. Se determin\u00f3 que la tasa de especificidad era mayor y que la tasa de interpretaci\u00f3n anormal era menor en el grupo <\/span>TD<\/span>. No hubo una diferencia estad\u00edsticamente significativa en la tasa de detecci\u00f3n de c\u00e1ncer entre los grupos <\/span>TD<\/span> y <\/span>MD<\/span>. Los autores concluyeron <\/span>que<\/span> entre las sobrevivientes de c\u00e1ncer de mama, la detecci\u00f3n de <\/span>TD<\/span> result\u00f3 en una mayor especificidad y menores falsos positivos sin afectar la tasa de detecci\u00f3n del c\u00e1ncer en comparaci\u00f3n con la mamograf\u00eda digital.<\/span>\u00a0<\/span><\/p>\n

\u00a0<\/span><\/p>\n

Tasas<\/b> de<\/b> fals<\/b>o<\/b>s negativ<\/b>os<\/b> de detecci\u00f3n de c\u00e1ncer de mama con y sin <\/b>tomos\u00edntesis<\/b> mamaria digital<\/b>\u00a0<\/span><\/h5>\n

Durand, M. A., <\/span>Friedewald<\/span>, S. M., <\/span>Plecha<\/span>, D. M., <\/span>Copit<\/span>, D. S., <\/span>Barke<\/span>, L. D., Rose, S. L., . . . Conant, E. F. (2021). <\/span>\u00a0<\/span><\/p>\n

False-Negative Rates of Breast Cancer Screening with and without Digital Breast Tomosynthesis. <\/span>\u00a0<\/span><\/p>\n

Radiology<\/span><\/i>,<\/span><\/i> 298<\/span><\/i>(2), 296-305. doi:10.1148\/radiol.2020202858<\/span>\u00a0<\/span><\/p>\n

https:\/\/pubs.rsna.org\/doi\/10.1148\/radiol.2020202858<\/span><\/a>\u00a0<\/span><\/p>\n

En este estudio, los autores trataron de comparar varios par\u00e1metros entre la detecci\u00f3n digital de la <\/span>tomos\u00edntesis<\/span> mamaria (<\/span>TD<\/span>) y la mamograf\u00eda digital (<\/span>MD<\/span>), incluyendo las tasas de falsos negativos (FN) y la detecci\u00f3n de c\u00e1nceres con resultados m\u00e1s favorables. Aproximadamente 380.000 ex\u00e1menes de detecci\u00f3n fueron revisados retrospectivamente. Aunque las tasas de FN fueron m\u00e1s bajas en el grupo <\/span>TD<\/span>, no hubo ninguna diferencia estad\u00edsticamente significativa en comparaci\u00f3n con<\/span> MD<\/span>. Sin <\/span>embargo, tanto las tasas de especificidad como las de sensibilidad fueron m\u00e1s altas en el grupo <\/span>TD<\/span> (P<.001 y P=.004, respectivamente). Adem\u00e1s, los c\u00e1nceres observados en <\/span>TD<\/span> eran a menudo<\/span> m\u00e1s<\/span> invasivos con menos met\u00e1stasis distantes o ganglios linf\u00e1ticos positivos en comparaci\u00f3n con los c\u00e1nceres observados en <\/span>MD<\/span>. Los autores concluyeron que se detect\u00f3 una mayor sensibilidad y especificidad, as\u00ed como la detecci\u00f3n de c\u00e1nceres con pron\u00f3sticos m\u00e1s favorables, con<\/span> detecci\u00f3n de<\/span> TD<\/span>.<\/span>\u00a0<\/span><\/p>\n

\u00a0<\/span><\/p>\n

Adici\u00f3n de Ultrasonido de mama de detecci\u00f3n a la mamograf\u00eda digital y la <\/b>tomos\u00edntesis<\/b> de mama digital para la detecci\u00f3n del c\u00e1ncer de mama en mujeres con riesgo promedio<\/b>\u00a0<\/span><\/h5>\n

Yi, A., Jang, M., <\/span>Yim<\/span>, D., Kwon, B. R., Shin, S. U., & Chang, J.M. (2021). <\/span>Adici\u00f3n<\/span> de <\/span>Yi, A., Jang, M., <\/span>Yim<\/span>, D., Kwon, B. R., Shin, S. U., & Chang, J. M. (2021). <\/span>\u00a0<\/span><\/p>\n

Addition of Screening Breast US to Digital Mammography and Digital Breast Tomosynthesis for Breast Cancer Screening in Women at Average Risk. <\/span>\u00a0<\/span><\/p>\n

Radiology<\/span><\/i>,<\/span><\/i> 298<\/span><\/i>(3), 568-575. doi:10.1148\/radiol.2021203134<\/span>\u00a0<\/span><\/p>\n

https:\/\/pubs.rsna.org\/doi\/10.1148\/radiol.2021203134<\/span><\/a>\u00a0<\/span><\/p>\n

En este estudio, los autores trataron de determinar el valor de agregar pruebas de detecci\u00f3n de ultrasonido mamario completo a la <\/span>tomos\u00edntesis<\/span> digital combinada de mamas y mamograf\u00eda digital (<\/span>TD<\/span>\/<\/span>MD<\/span>) en mujeres de riesgo promedio. Entre 2016 y 2018, 1.003 mujeres se sometieron a <\/span>TD<\/span>\/<\/span>MD<\/span> combinados y ultrasonido simult\u00e1neo de detecci\u00f3n de mamas enteras. Las tasas de detecci\u00f3n de c\u00e1ncer por cada 1.000 casos fueron de 9,0 y 12,0 solo para <\/span>TD<\/span>\/<\/span>MD<\/span> y <\/span>TD<\/span>\/M<\/span>D<\/span> con ultrasonido de cribado, respectivamente. En las mujeres con evaluaciones negativas de <\/span>TD<\/span>\/<\/span>MD<\/span>, el cribado de ultrasonido de mama result\u00f3 en una tasa de detecci\u00f3n de c\u00e1ncer de 3,2 por cada 1.000 ex\u00e1menes. Cabe destacar que estos 3 c\u00e1nceres se detectaron en mujeres con senos densos. Los autores concluyeron que la adici\u00f3n de ultrasonido mamario suplementario a <\/span>TD<\/span>\/<\/span>MD<\/span> aument\u00f3 modestamente la tasa de detecci\u00f3n de c\u00e1ncer y que un estudio prospectivo m\u00e1s amplio puede caracterizar a\u00fan m\u00e1s a las mujeres que se beneficiar\u00edan de la detecci\u00f3n <\/span>complementaria <\/span>con<\/span>l<\/span> ultrasonido<\/span>.<\/span>\u00a0<\/span><\/p>\n

\u00a0<\/span><\/p>\n

Factores asociados con <\/b>el realce del par\u00e9nquima <\/b>de fondo en la mamograf\u00eda<\/b> contrast<\/b>ada<\/b>\u00a0<\/span><\/h5>\n

Karimi, Z., Phillips, J., <\/span>Slanetz<\/span>, P., Lotfi, P., <\/span>Dialani<\/span>, V., Karimova, J., & Mehta, T. (2021). <\/span><\/p>\n

Factors Associated With Background Parenchymal Enhancement on Contrast-Enhanced Mammography. <\/span>\u00a0<\/span><\/p>\n

American Journal of Roentgenology,<\/span><\/i> 216<\/span><\/i>(2), 340-348. doi:10.2214\/ajr.19.22353<\/span>\u00a0<\/span><\/p>\n

https:\/\/www.ajronline.org\/doi\/abs\/10.2214\/AJR.19.22353<\/span><\/a>\u00a0<\/span><\/p>\n

En este estudio, los autores trataron de determinar la relaci\u00f3n entre una variedad de factores del paciente, incluyendo factores de riesgo de c\u00e1ncer de mama, terapia <\/span>endocrina, estado menstrual y densidad del tejido mamario, en relaci\u00f3n con <\/span>el realce del par\u00e9nquima <\/span>de fondo (BPE<\/span> por sus siglas en <\/span>ing\u00e9s<\/span> –<\/span>background<\/span> parenchymal<\/span> enhancement<\/span>) en la mamograf\u00eda <\/span>contrastada <\/span>(M<\/span>C<\/span>). Cinco radi\u00f3logos <\/span>de mama<\/span> revisaron retrospectivamente los estudios de <\/span>MC<\/span> de 202 pacientes. Se determin\u00f3 que los factores asociados con el alto BPE en la <\/span>MC<\/span> inclu\u00edan <\/span>ausencia de <\/span>antecedentes de terapia endocrina, estado <\/span>premenop\u00e1usic<\/span>o<\/span>, senos densos y edad m\u00e1s joven. No hubo una asociaci\u00f3n sustancial entre el tiempo de la <\/span>MC<\/span> y el \u00faltimo per\u00edodo menstrual para l<\/span>a<\/span>s pacientes <\/span>premenop\u00e1usic<\/span>a<\/span>s<\/span>. Los autores concluyeron que se observa un mayor BPE en pacientes con estado <\/span>premenop\u00e1usic<\/span>o<\/span>, edad m\u00e1s joven y senos densos. Los autores tambi\u00e9n determinaron que la coordinaci\u00f3n de la <\/span>MC<\/span> con los per\u00edodos menstruales de los pacientes puede no ser necesaria.<\/span>\u00a0<\/span><\/p>\n

\u00a0<\/span><\/p>\n

Lesiones de alto riesgo detectadas por biopsia guiada por RMN: Tasas de actualizaci\u00f3n en la escisi\u00f3n quir\u00fargica e implicaciones para el manejo<\/b>\u00a0<\/span><\/h5>\n

Michaels, A. Y., Ginter, P. S., <\/span>Dodelzon<\/span>, K., <\/span>Naunheim<\/span>, M. R., & Abbey, G. N. (2021). <\/span>\u00a0<\/span><\/p>\n

High-Risk Lesions Detected by MRI-Guided Core Biopsy: Upgrade Rates at Surgical Excision and Implications for Management. <\/span>\u00a0<\/span><\/p>\n

American Journal of Roentgenology,<\/span><\/i> 216<\/span><\/i>(3), 622-632. doi:10.2214\/ajr.20.23040<\/span>\u00a0<\/span><\/p>\n

https:\/\/www.ajronline.org\/doi\/abs\/10.2214\/AJR.20.23040<\/span><\/a>\u00a0<\/span><\/p>\n

En este estudio, los autores trataron de determinar las tasas actualiza<\/span>das de<\/span> malignidad de lesiones de alto riesgo (incluyendo hiperplasia ductal at\u00edpica, carcinoma lobular in situ, cicatriz radial, papiloma, apia epitelial plana e hiperplasia lobular at\u00edpica) diagnosticada con biopsia guiada por RMN. Ciento cincuenta y nueve lesiones de alto riesgo diagnosticadas por biopsia guiada por RMN fueron incluidas en el estudio y revisadas retrospectivamente. Aproximadamente el 8% de las lesiones se <\/span>recategorizaron<\/span> al carcinoma en el momento de la escisi\u00f3n quir\u00fargica. Las patolog\u00edas con las tasas de actualizaci\u00f3n maligna m\u00e1s altas incluyeron hiperplasia ductal at\u00edpica (22,5%) y at<\/span>i<\/span>pia epitelial plana (33,3%). Tambi\u00e9n determin\u00f3 que las lesiones de hiperplasia ductal at\u00edpica ten\u00edan una tasa de <\/span>recategorizaci\u00f3n<\/span> estad\u00edsticamente significativamente mayor que las lesiones de hiperplasia ductal no at\u00edpica (p=.005). Los autores concluyeron <\/span>que<\/span> de estas lesiones de alto riesgo, la hiperplasia ductal at\u00edpica requiere escisi\u00f3n quir\u00fargica. Las lesiones de alto riesgo restantes pueden justificar la vigilancia por im\u00e1genes en lugar de la escisi\u00f3n quir\u00fargica, dadas las tasas de <\/span>recategorizaci\u00f3n<\/span> maligna m\u00e1s bajas.<\/span>\u00a0<\/span><\/p>\n

\u00a0<\/span><\/p>\n

Frecuencia y resultados de nuevas lesiones sospechosas en la resonancia magn\u00e9tica mamaria en el entorno de la terapia <\/b>neoadjuvante<\/b>\u00a0<\/span><\/h5>\n

Eckstein, D. A., Price, E. R., Hayward, J. H., Joe, B. N., & Lee, A. Y. (2021). <\/span>\u00a0<\/span><\/p>\n

Frequency and Outcomes of New Suspicious Lesions on Breast MRI in the Setting of Neoadjuvant <\/span>Therapy. <\/span>\u00a0<\/span><\/p>\n

American Journal of Roentgenology,<\/span><\/i> 216<\/span><\/i>(3), 633-639. doi:10.2214\/ajr.20.22979<\/span>\u00a0<\/span><\/p>\n

https:\/\/www.ajronline.org\/doi\/abs\/10.2214\/AJR.20.22979<\/span><\/a>\u00a0<\/span><\/p>\n

En este estudio, los autores trataron de cuantificar y caracterizar nuevos hallazgos sobre<\/span> la resonancia magn\u00e9tica mamaria <\/span>en pacientes que se sometieron a quimioterapia <\/span>neoadjuvante<\/span>. Las resonancias magn\u00e9ticas mamarias de 297 mujeres fueron revisadas retrospectivamente, y se incluyeron 23 ex\u00e1menes de RMN con nuevas lesiones <\/span>BI-<\/span>RADS 4 en el estudio. Aproximadamente la mitad de las nuevas lesiones sospechosas observadas en la RMN mamaria fueron contralaterales al c\u00e1ncer de mama primario (56,5%), y la mayor\u00eda de las lesiones se clasificaron como masas (69,6%).\u00a0 Cabe destacar que todas las lesiones sospechosas se determinaron benignas en funci\u00f3n de la correlaci\u00f3n patol\u00f3gica o el seguimiento de las im\u00e1genes. Los autores concluyeron que en pacientes sometidos a quimioterapia <\/span>neoadjuvante<\/span>, el 5,5% de las resonancias magn\u00e9ticas mamarias de seguimiento mostraron una nueva lesi\u00f3n sospechosa. Sin embargo, no hubo lesiones sospechosas malignas. Los autores sugieren que se deben realizar estudios m\u00e1s amplios para determinar si<\/span> para<\/span> este tipo de lesiones sospechosas <\/span>se puede omitir<\/span> la biopsia <\/span>en esta<\/span> poblaci\u00f3n espec\u00edfica de c\u00e1ncer de mama.<\/span>\u00a0<\/span><\/p>\n

\u00a0<\/span><\/p>\n

Resultados por raza en la detecci\u00f3n del c\u00e1ncer de mama con tomos\u00edntesis digital de mama versus mamograf\u00eda digital<\/b>\u00a0<\/span><\/h5>\n

Alsheik<\/span>, N., Blount, L., <\/span>Qiong<\/span>, Q., Talley, M., Pohlman, S., <\/span>Troeger<\/span>, K., . . . Conant, E. (2021). <\/span>\u00a0<\/span><\/p>\n

Outcomes by Race in Breast Cancer Screening <\/span>With<\/span> Digital Breast Tomosynthesis Versus Digital Mammography. <\/span>\u00a0<\/span><\/p>\n

Journal of the American College of Radiology<\/span><\/i>. <\/span>doi:10.1016\/<\/span>j.jacr<\/span>.2020.12.033<\/span>\u00a0<\/span><\/p>\n

https:\/\/www.jacr.org\/article\/S1546-1440(21)00006-5\/fulltext<\/span><\/a>\u00a0<\/span><\/p>\n

En este estudio, los autores trataron de examinar las disparidades raciales <\/span>entre<\/span> las<\/span> modalidades de detecci\u00f3n del c\u00e1ncer de mama. Cerca de 400.000 mujeres fueron incluidas en el estudio, y se evaluaron tanto estudios digitales de tomos\u00edntesis mamaria (<\/span>TD<\/span>) como de mamograf\u00eda digital (<\/span>MD<\/span>). Se determin\u00f3 que las mujeres negras comprend\u00edan la proporci\u00f3n m\u00e1s baja de cribado con <\/span>TD<\/span> y <\/span>MD<\/span> combinados (44% en comparaci\u00f3n con 61<\/span>% para las mujeres cauc\u00e1sicas). La<\/span>s mujeres <\/span>no<\/span> cauc\u00e1seas fueron<\/span> m\u00e1s propensas a tener una sola modalidad de detecci\u00f3n mamogr\u00e1fica, y las tasas de recuperaci\u00f3n eran m\u00e1s altas en mujeres con una sola mamograf\u00eda. Tambi\u00e9n se determin\u00f3 que el valor predictivo positivo para las tasas de <\/span>recordaci\u00f3n<\/span> y detecci\u00f3n de c\u00e1ncer era similar o mayor para las mujeres sometidas a <\/span>TD<\/span> y <\/span>MD<\/span> combinadas en general y basadas en la edad y la raza (P<.0001 y P=.0005, respectivamente). Los autores concluyeron que todos los grupos raciales demostraron mejores resultados de <\/span>cribado con <\/span>TD<\/span> y DM combinados. Sin embargo, las mujeres no cauc\u00e1sicas, en particular las negras, eran menos propensas a recibir ex\u00e1menes combinados. Los autores sugieren que aumentar el acceso a las modalidades combinadas de <\/span>TD<\/span> y <\/span>MD<\/span>
\npueden mejorar la inequidad y la eficacia de la detecci\u00f3n del c\u00e1ncer de mama.<\/span>\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"Traducido por – Luis Alberto Albarado\u00a0\u00a0 Rv Daniela Segura – Radi\u00f3loga ACORE Team Leader Colombia\u00a0 […]","protected":false},"author":3,"featured_media":3019,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[208],"tags":[],"class_list":["post-13584","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categorizar"],"yoast_head":"\nWhat's new in Breast Imaging (Spanish) - April 2021 - ACORE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-april-2021\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"What's new in Breast Imaging (Spanish) - April 2021 - ACORE\" \/>\n<meta property=\"og:description\" content=\"Traducido por – Luis Alberto Albarado\u00a0\u00a0 Rv Daniela Segura – Radi\u00f3loga ACORE Team Leader Colombia\u00a0 […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-april-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"ACORE\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-22T14:28:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-04-22T14:29:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/female-hands-joined-in-circle-holding-pink-ribbons-RCN683A-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"2560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Abdelrahman\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Abdelrahman\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-april-2021\/\",\"url\":\"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-april-2021\/\",\"name\":\"What's new in Breast Imaging (Spanish) - April 2021 - ACORE\",\"isPartOf\":{\"@id\":\"https:\/\/staging-hub.acoredu.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-april-2021\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-april-2021\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/female-hands-joined-in-circle-holding-pink-ribbons-RCN683A-scaled.jpg\",\"datePublished\":\"2021-04-22T14:28:54+00:00\",\"dateModified\":\"2021-04-22T14:29:43+00:00\",\"author\":{\"@id\":\"https:\/\/staging-hub.acoredu.com\/#\/schema\/person\/75293c6e4870f3aa293e1394c53df6b7\"},\"breadcrumb\":{\"@id\":\"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-april-2021\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-april-2021\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-april-2021\/#primaryimage\",\"url\":\"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/female-hands-joined-in-circle-holding-pink-ribbons-RCN683A-scaled.jpg\",\"contentUrl\":\"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/female-hands-joined-in-circle-holding-pink-ribbons-RCN683A-scaled.jpg\",\"width\":2560,\"height\":2560,\"caption\":\"Breast Cancer. Female Hands Joined In Circle Holding Pink Ribbons On White Background. View From Above, Shallow Depth\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-april-2021\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/staging-hub.acoredu.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"What’s new in Breast Imaging (Spanish) – April 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging-hub.acoredu.com\/#website\",\"url\":\"https:\/\/staging-hub.acoredu.com\/\",\"name\":\"ACORE\",\"description\":\"Radiology education for everyone, everywhere!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging-hub.acoredu.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging-hub.acoredu.com\/#\/schema\/person\/75293c6e4870f3aa293e1394c53df6b7\",\"name\":\"Abdelrahman\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/staging-hub.acoredu.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2ad7486277da081678ef5e7172d9abecba77465cd62bd4d7272d1141d0b9bca2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2ad7486277da081678ef5e7172d9abecba77465cd62bd4d7272d1141d0b9bca2?s=96&d=mm&r=g\",\"caption\":\"Abdelrahman\"},\"url\":\"https:\/\/staging-hub.acoredu.com\/es\/author\/abdelrahman\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"What's new in Breast Imaging (Spanish) - April 2021 - ACORE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-april-2021\/","og_locale":"es_ES","og_type":"article","og_title":"What's new in Breast Imaging (Spanish) - April 2021 - ACORE","og_description":"Traducido por – Luis Alberto Albarado\u00a0\u00a0 Rv Daniela Segura – Radi\u00f3loga ACORE Team Leader Colombia\u00a0 […]","og_url":"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-april-2021\/","og_site_name":"ACORE","article_published_time":"2021-04-22T14:28:54+00:00","article_modified_time":"2021-04-22T14:29:43+00:00","og_image":[{"width":2560,"height":2560,"url":"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/female-hands-joined-in-circle-holding-pink-ribbons-RCN683A-scaled.jpg","type":"image\/jpeg"}],"author":"Abdelrahman","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Abdelrahman","Tiempo de lectura":"8 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-april-2021\/","url":"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-april-2021\/","name":"What's new in Breast Imaging (Spanish) - April 2021 - ACORE","isPartOf":{"@id":"https:\/\/staging-hub.acoredu.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-april-2021\/#primaryimage"},"image":{"@id":"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-april-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/female-hands-joined-in-circle-holding-pink-ribbons-RCN683A-scaled.jpg","datePublished":"2021-04-22T14:28:54+00:00","dateModified":"2021-04-22T14:29:43+00:00","author":{"@id":"https:\/\/staging-hub.acoredu.com\/#\/schema\/person\/75293c6e4870f3aa293e1394c53df6b7"},"breadcrumb":{"@id":"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-april-2021\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-april-2021\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-april-2021\/#primaryimage","url":"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/female-hands-joined-in-circle-holding-pink-ribbons-RCN683A-scaled.jpg","contentUrl":"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/female-hands-joined-in-circle-holding-pink-ribbons-RCN683A-scaled.jpg","width":2560,"height":2560,"caption":"Breast Cancer. Female Hands Joined In Circle Holding Pink Ribbons On White Background. View From Above, Shallow Depth"},{"@type":"BreadcrumbList","@id":"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-april-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/staging-hub.acoredu.com\/"},{"@type":"ListItem","position":2,"name":"What’s new in Breast Imaging (Spanish) – April 2021"}]},{"@type":"WebSite","@id":"https:\/\/staging-hub.acoredu.com\/#website","url":"https:\/\/staging-hub.acoredu.com\/","name":"ACORE","description":"Radiology education for everyone, everywhere!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging-hub.acoredu.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/staging-hub.acoredu.com\/#\/schema\/person\/75293c6e4870f3aa293e1394c53df6b7","name":"Abdelrahman","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/staging-hub.acoredu.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/2ad7486277da081678ef5e7172d9abecba77465cd62bd4d7272d1141d0b9bca2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2ad7486277da081678ef5e7172d9abecba77465cd62bd4d7272d1141d0b9bca2?s=96&d=mm&r=g","caption":"Abdelrahman"},"url":"https:\/\/staging-hub.acoredu.com\/es\/author\/abdelrahman\/"}]}},"_links":{"self":[{"href":"https:\/\/staging-hub.acoredu.com\/es\/wp-json\/wp\/v2\/posts\/13584","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staging-hub.acoredu.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staging-hub.acoredu.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staging-hub.acoredu.com\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/staging-hub.acoredu.com\/es\/wp-json\/wp\/v2\/comments?post=13584"}],"version-history":[{"count":2,"href":"https:\/\/staging-hub.acoredu.com\/es\/wp-json\/wp\/v2\/posts\/13584\/revisions"}],"predecessor-version":[{"id":13586,"href":"https:\/\/staging-hub.acoredu.com\/es\/wp-json\/wp\/v2\/posts\/13584\/revisions\/13586"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/staging-hub.acoredu.com\/es\/wp-json\/wp\/v2\/media\/3019"}],"wp:attachment":[{"href":"https:\/\/staging-hub.acoredu.com\/es\/wp-json\/wp\/v2\/media?parent=13584"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging-hub.acoredu.com\/es\/wp-json\/wp\/v2\/categories?post=13584"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staging-hub.acoredu.com\/es\/wp-json\/wp\/v2\/tags?post=13584"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}